POLYMORPHISMS IN CACHEXIA PREDICT CLINICAL OUTCOMES OF COLORECTAL CANCER PATIENTS RECEIVING IRINOTECAN AND BEVACIZUMAB

• 收藏
• 分享

专利权人:

发明人:

Heinz-Josef Lenz

申请号：

US15962185

公开号：

US20180311347A1

申请日:

2018.04.25

申请国别(地区):

US

年份:

2018

代理人:

摘要：

Methods are provided for treating colorectal cancer patients with a therapy comprising irinotecan and bevacizumab. The methods entail administering the therapy to the patient if the patient has specific rs1792689, rs2268753, rs17776182, rs7570532 and/or rs4946935 polymorphisms.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/